Katherine Young
9Patents
2h-index
70Co-inventors
50Inventor score
Filing activity: May 21, 2007 → Apr 29, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9708336B2 | Metallo-beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 4 | Active |
| US10947205B2 | Oxazolidinone compounds and methods of use thereof as antibacterial agents | Chemistry; Metallurgy | 4 | Active |
| US10221163B2 | Metallo-beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10227331B2 | Metallo-β-lactamase inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US10544130B2 | Metallo-beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US9944654B2 | Nargenicin compounds and uses thereof as antibacterial agents | Chemistry; Metallurgy | 0 | Active |
| US10144741B2 | Nargenicin compounds and uses thereof as antibacterial agents | Chemistry; Metallurgy | 0 | Active |
| US8440643B2 | Inhibitors of beta-lactamase | Chemistry; Metallurgy | 0 | Active |
| US11180504B2 | Substituted carbapenems for the treatment of bacterial infections | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.